Addex achieves preclinical milestone in agreement with Merck & Co. for allosteric modulators Feb. 28, 2008
Javelin completes subject accrual in the last of four phase I clinical studies of PMI-150 Feb. 28, 2008
Glatiramer and steroid combination treatment beneficial in relapsing-remitting multiple sclerosis Feb. 28, 2008
RSS